Company / Free Cash Flow per Share
IOVANCE BIOTHERAPEUTICS, INC. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.10
FY2025
5-year range
-$1966.49 / -$1.10
FY2021-FY2025
Trend
+22.5%
vs FY2024
Sector context
#105 of 192
Health Care
What the data says
At $-1.10, IOVANCE BIOTHERAPEUTICS, INC.'s free cash flow per share ranks #105 of 192 in the Health Care sector. Free Cash Flow per Share has increased for 3 consecutive years, from $-1966.49 in FY2022 to $-1.10 in FY2025.
Based on SEC 10-K filings.
-1.10 in FY2025.
Improved from $-2.05 to $-1.10 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#105 of 192 in Health CareTop 55% of 192This company -$1.10 Sector average $3.32
▼
-133.2% below sector average
Key checks
Key Insights
- IOVANCE BIOTHERAPEUTICS, INC.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 22.5% year-over-year.
- Ranks #105 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.10 | +22.5% |
| FY2024 | -$1.42 | +30.5% |
| FY2023 | -$2.05 | +99.9% |
| FY2022 | -$1966.49 | -13.6% |
| FY2021 | -$1730.80 | +5.0% |
| FY2020 | -$1821.57 | -36.6% |
| FY2019 | -$1333.53 | -95137.3% |
| FY2018 | -$1.40 | -9.3% |
| FY2017 | -$1.28 | -508.2% |
| FY2016 | -$0.21 | -93.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026